The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ages 12 years and older, GSK announced on Thursday. "The ability of N.

Forger takes a more favorable view toward the devices, which he says help keep the overlooked importance of sleep front of mind. He recommends them even for people without significant sleep issues, ...